Andere Kunden interessierten sich auch für
![Examining the Long-run Relationship Between South African and United States Markets]( "Examining the Long-run Relationship Between South African and United States Markets")
Examining the Long-run Relationship Between South African and United States Markets36,99 €![The Indian Pharmaceutical Industry]( "The Indian Pharmaceutical Industry")
The Indian Pharmaceutical Industry37,99 €![Foreign Economic Policy for the United States]( "Foreign Economic Policy for the United States")
Foreign Economic Policy for the United States60,00 €![The United States of America, Volume 2]( "The United States of America, Volume 2")
The United States of America, Volume 2103,99 €![Future Trading Upon Organized Commodity Markets in the United States]( "Future Trading Upon Organized Commodity Markets in the United States")
Future Trading Upon Organized Commodity Markets in the United States93,99 €![Banking Theories in the United States Before 1860]( "Banking Theories in the United States Before 1860")
Banking Theories in the United States Before 186043,99 €![Political Instability in the United Kingdom]( "Political Instability in the United Kingdom")
Political Instability in the United Kingdom26,99 €
The purpose of this case study was to learn how US patent policy requirements differ for the Software and Pharmaceutical Industries, specifically if United States Patent Policy adequately protects intellectual property rights (IPR) for two divergent industries while still encouraging research and development (R & D) investment sufficient to increase profits and innovation. Data for this study consisted of 38 witness testimonies delivered to US Congress between the years 2005 and 2010 by experts representing the two industries of interest: pharmaceutical and software.